- Home
- MXCT vs DCGO Comparison
MXCT vs DCGO Comparison
Compare MXCT & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- DCGO
- Stock Information
- Founded
- MXCT 1999
- DCGO 2015
- Country
- MXCT United States
- DCGO United States
- Employees
- MXCT N/A
- DCGO N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DCGO Managed Health Care
- Sector
- MXCT Health Care
- DCGO Health Care
- Exchange
- MXCT Nasdaq
- DCGO Nasdaq
- Market Cap
- MXCT 159.9M
- DCGO 136.0M
- IPO Year
- MXCT 2021
- DCGO N/A
- Fundamental
- Price
- MXCT $1.76
- DCGO $1.25
- Analyst Decision
- MXCT Buy
- DCGO Strong Buy
- Analyst Count
- MXCT 4
- DCGO 3
- Target Price
- MXCT $7.50
- DCGO $3.37
- AVG Volume (30 Days)
- MXCT 841.1K
- DCGO 813.7K
- Earning Date
- MXCT 11-05-2025
- DCGO 11-06-2025
- Dividend Yield
- MXCT N/A
- DCGO N/A
- EPS Growth
- MXCT N/A
- DCGO N/A
- EPS
- MXCT N/A
- DCGO N/A
- Revenue
- MXCT $35,754,000.00
- DCGO $435,968,564.00
- Revenue This Year
- MXCT N/A
- DCGO N/A
- Revenue Next Year
- MXCT $14.80
- DCGO N/A
- P/E Ratio
- MXCT N/A
- DCGO N/A
- Revenue Growth
- MXCT N/A
- DCGO N/A
- 52 Week Low
- MXCT $1.26
- DCGO $1.12
- 52 Week High
- MXCT $5.20
- DCGO $5.68
- Technical
- Relative Strength Index (RSI)
- MXCT 57.62
- DCGO 39.36
- Support Level
- MXCT $1.52
- DCGO $1.23
- Resistance Level
- MXCT $1.84
- DCGO $1.33
- Average True Range (ATR)
- MXCT 0.11
- DCGO 0.07
- MACD
- MXCT 0.02
- DCGO 0.00
- Stochastic Oscillator
- MXCT 79.22
- DCGO 45.45
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.